Find a Product

Webinar: Immuno-Oncology Drug Development: Profiling Immunomodulatory Biologics and Compounds in Human Primary Cell-Based Oncology Models

Kinase dendrogram
 
     

Friday, September 30, 2016

Watch Now
(50-minute seminar, 10-minute Q&A)
 

The complex interactions between tumor cells and the host immune system are only beginning to be understood, however it is clear that manipulating this interaction can have dramatic effects on tumor clearance. As this biology is still relatively under-explored, it is difficult to design tools that easily and rapidly identify compounds capable of modulating the immune system in the context of a tumor microenvironment. DiscoverX has put together a comprehensive portfolio of products and services that enable fast, effective and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms.

What will be covered?

  • Overview of the BioMAP® immuno-oncology/oncology systems
  • Information BioMAP iOnc studies provide
  • Host stromal/vascular - tumor microenvironment biology
  • Case studies of profiling Ab therapies (anti-PD-1, anti-CTLA-4, etc.) and preclinical compounds